快速基因组测序与疑似遗传疾病的重症婴儿的基因小组相比:经济评估

Tara A Lavelle1,2, Jill L Maron3, Stephen F Kingsmore4

  • 1Center for the Evaluation of Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St., #063, Boston, Massachusetts, 02111, USA.

概括

针对重症婴儿的快速基因组测序 (rGS) 可以节省大量的医疗保健费用. 早期的rGS比向基因测序更具成本效益,支持扩大保险覆盖范围以更快地诊断.